Posted April 18, 2017 at 12:13 PM EST
Illustration by Kimberly Lum for Institutional Investor.
How to stay prudent when the market is partying like it’s (precrash) 1999.
Posted March 24, 2017 at 1:00 AM EST
The company is a shining star in the business process outsourcing industry, says Vitaliy Katsenelson, CIO at Investment Management Associates.
Posted March 8, 2017 at 4:09 PM EST
Mylan NV's logo is displayed on a box of EpiPen 2-Pak allergy (Photo credit: Daniel Acker/Bloomberg).
In my previous column I explained why we are partial to pharmaceuticals, a sector politicians love to hate. Here’s how we’re playing our view.
Posted March 2, 2017 at 2:38 PM EST
Illustration by Alex Agius for Institutional Investor.
Pharmaceuticals stocks have been in the crosshairs of politicians on both sides of the aisle. But the noise has created buying opportunities.